Tofranil: Effective Relief for Depression and Bedwetting

Tofranil

Tofranil

Price from 40.00 $
Product dosage: 25mg
Package (num)Per pillPriceBuy
60$0.67$40.26 (0%)🛒 Add to cart
90$0.60$60.40 $54.36 (10%)🛒 Add to cart
120$0.57$80.53 $68.45 (15%)🛒 Add to cart
180$0.54$120.79 $97.64 (19%)🛒 Add to cart
270$0.51$181.19 $137.91 (24%)🛒 Add to cart
360
$0.50 Best per pill
$241.59 $179.18 (26%)🛒 Add to cart
Product dosage: 50mg
Package (num)Per pillPriceBuy
60$0.96$57.38 (0%)🛒 Add to cart
90$0.89$86.07 $80.53 (6%)🛒 Add to cart
120$0.86$114.75 $102.68 (11%)🛒 Add to cart
180$0.83$172.13 $148.98 (13%)🛒 Add to cart
270$0.81$258.20 $218.44 (15%)🛒 Add to cart
360
$0.80 Best per pill
$344.26 $286.89 (17%)🛒 Add to cart
Product dosage: 75mg
Package (num)Per pillPriceBuy
60$0.99$59.39 (0%)🛒 Add to cart
90$0.92$89.09 $82.54 (7%)🛒 Add to cart
120$0.89$118.78 $106.70 (10%)🛒 Add to cart
180$0.86$178.17 $154.01 (14%)🛒 Add to cart
270$0.83$267.26 $223.47 (16%)🛒 Add to cart
360
$0.82 Best per pill
$356.34 $293.93 (18%)🛒 Add to cart
Synonyms

Tofranil (imipramine hydrochloride) is a tricyclic antidepressant (TCA) with a well-established history in managing major depressive disorders and nocturnal enuresis in children. It functions by restoring the balance of certain natural substances (neurotransmitters) in the brain, namely serotonin and norepinephrine. This medication is prescribed for its efficacy in improving mood, sleep, appetite, and energy levels, while also reducing anxiety and fear related to depression. Available in tablet form, it requires a prescription and should be used under strict medical supervision to maximize therapeutic outcomes and minimize risks.

Features

  • Active ingredient: Imipramine hydrochloride
  • Drug class: Tricyclic antidepressant (TCA)
  • Available in 10 mg, 25 mg, and 50 mg oral tablets
  • Requires a prescription from a licensed healthcare provider
  • Manufactured under strict pharmaceutical quality controls
  • Typically supplied in bottles or blister packs

Benefits

  • Effectively alleviates symptoms of major depressive disorder, including low mood and loss of interest
  • Helps restore normal sleep patterns and improves overall energy levels
  • Reduces anxiety and nervousness associated with depression
  • Proven efficacy in treating bedwetting (nocturnal enuresis) in children aged 6 years and older
  • May provide relief for certain chronic pain conditions when used off-label under medical guidance
  • Supports long-term mental wellness when combined with therapy and lifestyle adjustments

Common use

Tofranil is primarily indicated for the treatment of major depressive disorder in adults. It is also approved for the management of nocturnal enuresis in children aged 6 years and older who do not respond to non-pharmacological interventions. Off-label, it may be used in the management of certain anxiety disorders, neuropathic pain, and migraine prophylaxis, though such use should be carefully evaluated and monitored by a healthcare professional.

Dosage and direction

Dosage must be individualized based on the patient’s condition, age, and response to treatment. For depression in adults, the initial dose is usually 75 mg daily, which may be increased gradually under medical supervision. Maintenance doses typically range from 50 mg to 150 mg per day, though some patients may require up to 300 mg daily in divided doses. For nocturnal enuresis in children, the recommended starting dose is 25 mg taken one hour before bedtime; this may be adjusted based on response and tolerability, not exceeding 50 mg nightly in children aged 6–12 years, or 75 mg nightly in those over 12. Tablets should be swallowed whole with water, with or without food, though taking with meals may reduce gastrointestinal discomfort. Dosage adjustments should only be made under the guidance of a prescribing physician.

Precautions

Patients should be monitored closely for worsening depression, suicidal thoughts, or unusual changes in behavior, especially when starting treatment or after dosage changes. Tofranil may cause drowsiness or dizziness; caution is advised when driving or operating machinery. Regular monitoring of blood pressure and heart rate is recommended, as TCAs can affect cardiovascular function. Use with caution in patients with a history of seizures, urinary retention, narrow-angle glaucoma, or thyroid disorders. Alcohol should be avoided, as it can intensify side effects. Elderly patients may be more sensitive to anticholinergic and sedative effects.

Contraindications

Tofranil is contraindicated in patients with known hypersensitivity to imipramine or other tricyclic antidepressants. It should not be used during the acute recovery phase after myocardial infarction or in individuals with a history of severe heart disorders. Concomitant use with monoamine oxidase inhibitors (MAOIs) is contraindicated due to risk of serotonin syndrome; a washout period of at least 14 days is required when switching between these classes of drugs. It is also contraindicated in patients with untreated narrow-angle glaucoma or severe liver impairment.

Possible side effect

Common side effects may include dry mouth, drowsiness, dizziness, constipation, blurred vision, and weight gain. Less frequently, patients may experience orthostatic hypotension, increased heart rate, sweating, or urinary retention. Serious side effects, though rare, can include seizures, hallucinations, signs of infection (e.g., sore throat, fever), jaundice, or irregular heartbeat. Any unusual or severe reactions should be reported to a healthcare provider immediately.

Drug interaction

Tofranil may interact with numerous medications, including MAOIs (risk of serotonin syndrome), other antidepressants, antihypertensives, anticonvulsants, and central nervous system depressants like alcohol or benzodiazepines. It can potentiate the effects of drugs with anticholinergic properties. Concomitant use with sympathomimetics or thyroid medications may increase the risk of cardiovascular side effects. Always inform your healthcare provider of all prescription, over-the-counter, and herbal products you are using.

Missed dose

If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up. Consistent dosing is important for maintaining therapeutic levels, so try to adhere to the prescribed regimen.

Overdose

Overdose of Tofranil can be life-threatening and may manifest as severe drowsiness, agitation, confusion, seizures, irregular heartbeat, dilated pupils, or coma. Symptoms require immediate medical attention. Treatment is supportive and may include gastric lavage, activated charcoal, and management of cardiac and respiratory complications. Contact a poison control center or emergency room without delay if overdose is suspected.

Storage

Store Tofranil tablets at room temperature (15–30°C or 59–86°F), in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Dispose of unused medication properly, following local guidelines or through a drug take-back program.

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Do not ignore or delay seeking professional medical advice based on information read here.

Reviews

Clinical studies and patient reports generally reflect Tofranil’s efficacy in treating depression and nocturnal enuresis, with many users noting significant improvement in mood and reduction in bedwetting episodes. However, experiences with side effects vary; some patients tolerate it well, while others discontinue due to adverse reactions. Long-term users often emphasize the importance of medical supervision and gradual dosage titration. Individual results may differ.